TG4050 elicits strong polyepitopic, polyclonal, durable cytotoxic and effector neoantigen-specific CD8 T cell responses Results reinforce TG4050 ...

Twenty years on since the approval of the first human papillomavirus (HPV) vaccine, a raft of studies involving millions of people have reached the same conclusion: HPV vaccination is safe and ...

A new study has found that high uptake of school-based immunisation against human papillomavirus (HPV) could also offer ...

Paula Creed recently joined the staff of the Brevard Achievement Center as its talent support coordinator. Creed, who has ...

In Alabama, facing top-tier cervical cancer rates, health officials launch "Operation Wipeout," aiming to eradicate the ...

A UVA Health physician helped shape new guidelines to expand at-home testing and prevent cancer before it starts.

"Recent scientific studies have shown that one dose of the HPV vaccine is as effective as two doses," an HHS fact sheet ...

Transgene (TRGNF, TNG.PA), a biotechnology company developing virus-based immunotherapies for cancer, announced the preprint ...

A single HPV vaccine dose could prevent 90% of cervical cancers. But disinformation and political ideology are spooking some ...

NHS South West aims to eliminate cervical cancer by 2040 through increased HPV vaccination and cervical screening. Learn more about prevention ...